A detailed history of Fieldpoint Private Securities, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 650 shares of INVA stock, worth $12,284. This represents 0.0% of its overall portfolio holdings.

Number of Shares
650
Previous 1,330 51.13%
Holding current value
$12,284
Previous $26,000 61.54%
% of portfolio
0.0%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$14.32 - $19.88 $9,737 - $13,518
-680 Reduced 51.13%
650 $10,000
Q1 2022

Apr 07, 2022

SELL
$15.39 - $20.25 $7,233 - $9,517
-470 Reduced 26.11%
1,330 $26,000
Q4 2021

Jan 24, 2022

BUY
$15.91 - $18.72 $11,932 - $14,040
750 Added 71.43%
1,800 $31,000
Q2 2021

Aug 12, 2021

BUY
$11.45 - $13.96 $4,408 - $5,374
385 Added 57.89%
1,050 $16,000
Q1 2021

Apr 23, 2021

BUY
$11.06 - $12.87 $6,248 - $7,271
565 Added 565.0%
665 $8,000
Q4 2020

Jan 28, 2021

BUY
$9.33 - $12.48 $933 - $1,248
100 New
100 $1,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.32B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.